IARC – International Agency for Research on Cancer / World Health Organization shared a post on LinkedIn:
“Last week, IARC Director Dr Elisabete Weiderpass met with key national leaders in Mexico to strengthen collaborations and explore Mexico’s path to becoming an IARC Participating State.
Highlights from the visit include:
In-depth discussions with Dr Eduardo Lazcano and Dr Martin Lajous of the Instituto Nacional de Salud Pública. A special thanks to Dr Lajous for his invaluable support in enabling the visit and facilitating high-level meetings.
An engaging exchange Cancer Control challenges and opportunities with the Fundación Cáncer Warriors de México. We’re deeply grateful to Cancer Warriors’ President and Union for International Cancer Control (UICC) Treasurer Kenji López-Cuevas, for his leadership in advancing IARC – Mexico collaboration and coordinating a rich program of official meetings.
Official meetings with Senator Cynthia López Castro, who is also Global President of Women Parliamentarians at the Inter-Parliamentary Union, and Senator Jose Manuel Cruz Castillanos, Chair of the Secretaría de Salud del Gobierno de México, on Mexico’s potential accession to IARC. These meetings took place in the Cámara de Senadores – México and the visit was formally recognized in the Senate plenary, a powerful sign of support for IARC and cancer control.
A constructive meeting with Dr David Kershenobich, Minister of Health, and Eduardo Clark, Undersecretary of Health, to explore strategic opportunities for cancer control.
Productive engagement with Dr Bernardo Cacho Díaz, Medical Director of the Instituto Nacional de Cancerología, on strengthening technical collaboration.
We warmly thank all our Mexican partners and allies for their trust and commitment. This visit marks an important step toward deepening international collaboration and enhancing high-quality Cancer Research to reduce the burden of Cancer in Mexico.”
More posts featuring IARC – International Agency for Research on Cancer / World Health Organization on OncoDaily.
